anti cd133 monoclonal antibodies Articles
1 articles found
-
Cancer stem–like cells photothermolysed by gold nanorod–mediated near–infrared laser irradiation
Several studies have recently identified CD133 as a marker of cancer stem–like cells (CSCs) for various tumours. Such findings make CD133 a potential molecular target for tumour–selective therapeutic approach. In this study, fluorescence–tagged CD133 monoclonal antibody (anti–CD133) was conjugated to gold nanorods (GNRs), which are one of the anisotropic nanomaterials that can absorb ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you